Armbruster Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Armbruster Capital Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-675	Closed	-$28K	–	288
2016 Q2	$28K	Sell	675 -575	-46%	-$24.4K	0.02%	168
2016 Q1	$50K	Hold	1,250	–	–	0.03%	129
2015 Q4	$64K	Buy	+1,250	New	+$63.7K	0.06%	113

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Armbruster Capital Management's XPH Position: Q3 2016 in Review

Armbruster Capital Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2016, closing a stake of 675 shares — an estimated $28K sold.

Armbruster Capital Management first reported a position in XPH in Q4 2015 and held it in 3 quarters. The position peaked at $64K in Q4 2015. 69 funds tracked by Wall St. Rank hold XPH as of Q3 2016.

Armbruster Capital Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2016 after selling out during the quarter.
Armbruster Capital Management sold 675 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2016, an estimated $28K.
Armbruster Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2015 and held it in 3 quarters.
Armbruster Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $64K in Q4 2015.
69 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2016.

Based on Armbruster Capital Management's 13F filing for Q3 2016, filed 25 Oct 2016.